ANTX - AN2 Therapeutics Inc
5.46
0.210 3.846%
Share volume: 4,201,527
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$5.25
0.21
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-25-2025 | 05-13-2025 | 11-12-2025 | |
| Cash flow financing | 349.000 K | 0.000 | 23.000 K | 0.000 | 65.000 K | 48.000 K | |
| Other financing cash flows | 225.000 K | 0.000 | 0.000 | 0.000 | 27.000 K | 0.000 | |
| Cash flow | 9.046 M | 0.000 | 6.735 M | 0.000 | -1.366 M | -217.000 K | |
| Net income | -16.617 M | -14.435 M | -12.747 M | -7.522 M | -10.649 M | -9.353 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 26.290 M | 16.460 M | 18.719 M | -6.880 M | 9.193 M | 6.110 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 9.046 M | 2.076 M | 6.735 M | -12.153 M | -1.366 M | -217.000 K |